Potentiation of bronchomotor responses by beta adrenergic antagonists.
D000083:Acetanilides / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000403:Airway Resistance / Q000187:drug effects*; D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001980:Bronchi / Q000187:drug effects*; D001986:Bronchial Spasm / Q000139:chemically induced; D004285:Dogs; D004357:Drug Synergism; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology*; D008297:Male; D009578:Nitrobenzenes / Q000494:pharmacology; D010096:Oxprenolol / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D012129:Respiratory Function Tests / Q000295:instrumentation; D013015:Sotalol / Q000494:pharmacology; D013147:Spirometry; D013562:Sympathectomy; D013565:Sympatholytics / Q000494:pharmacology*
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D009578:Nitrobenzenes; D010627:Phenethylamines; D011437:Propylamines; D013565:Sympatholytics; D010096:Oxprenolol; D006632:Histamine; D011433:Propranolol; D013015:Sotalol; D006145:Guanethidine